Alembic Limited

Vadodara, India Founded: 1907 • Age: 119 yrs
Active pharmaceutical ingredients are manufactured by Alembic.
Annual revenue $26.0M Latest available
Total funding - Funding intelligence
Employees 323 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Alembic Limited

Alembic Limited is a company based in Vadodara (India) founded in 1907. The company has 323 employees as of March 31, 2024. Alembic Limited operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.

  • Headquarter Vadodara, India
  • Employees 323 as on 31 Mar, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Alembic Limited
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $25.99 M (USD)
    40.97
    as on Mar 31, 2025
  • Net Profit
    $36.4 M (USD)
    15.66
    as on Mar 31, 2025
  • EBITDA
    $11.03 M (USD)
    65.17
    as on Mar 31, 2025
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    323

    as on Mar 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Alembic Limited

Alembic Limited is a publicly listed company on the NSE with ticker symbol ALEMBICLTD in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: ALEMBICLTD · Sector: Health technology · India

Funding Insights of Alembic Limited

Premium access

Detailed funding history for Alembic Limited

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Alembic Limited

Investments
Premium access

Investment portfolio details for Alembic Limited

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Alembic Limited

Premium access

Detailed financials for Alembic Limited

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Alembic Limited Comparisons

Alembic Limited Primary company
Description
Active pharmaceutical ingredients are manufactured by Alembi...
Location
Vadodara, India
Founded Year
1907
Annual Revenue
$25.99 M (USD)
Net Profit
$36.4 M (USD)
EBITDA
$11.03 M (USD)
Employees
323
As of 2024
Premium access

Peer comparison for Alembic Limited

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Alembic Limited

Alembic Limited operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Pharmaceutical products are manufactured and marketed worldwide.
Locked Locked Locked
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
Locked Locked Locked
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
Locked Locked Locked
Traditional pharmaceutical medicines are developed for multiple health fields.
Locked Locked Locked
Developer of drugs for the treatment of multiple disorders
Locked Locked Locked
Biopharmaceutical research and drug development are conducted globally by AbbVie.
Premium access

Detailed competitors of Alembic Limited

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Alembic Limited

Premium access

Complete news archive for Alembic Limited

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alembic Limited

Alembic Limited was founded in 1907.

Alembic Limited is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.

Malika C Amin is the current CEO of Alembic Limited.

As of Mar 31, 2024, the latest employee count at Alembic Limited is 323.

Annual revenue of Alembic Limited is $25.99M as on Mar 31, 2025.

Alembic was established in 1907 and is headquartered in Vadodara, India. Operations focus on the production of active pharmaceutical ingredients within the healthcare sector. The company maintains facilities for manufacturing these essential components used in drug formulations. Leadership is provided by Malika C Amin as CEO and Managing Director. Activities are centered in the pharmaceutical industry, supporting global supply chains from its Indian base.

Alembic Limited's top competitors include Merck, Roivant Sciences and AbbVie.

Yes, Alembic Limited is publicly traded on NSE under the ticker symbol ALEMBICLTD.

The ticker symbol of Alembic Limited is ALEMBICLTD on NSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available